News
Research Innovation
Plasma donation
Product Center
Career Development
Human Hepatitis B Immunoglobulin (pH4) for Intravenous Injection
36 months
Each vial contains 2000IU (40ml) anti-HBs.
SFDA Approval No. S20083007
Combination with lamivudine for the prevention of hepatitis B virus (HBV) re-infection in liver transplant patients.